Details of HTA journal title
Last updated: 5 August 2008 - Next update due: 12 August 2008
Research type: |
NICE Technology Assessment Report (TAR) |
Title (lead author) etc: |
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation (Colquitt) 222 pages, Volume 12, number 16 |
Link to NICE guidance page |
|
View/print executive summary
View/print abstract
View full text in pdf format (1185 KB)
Go to our correspondence page to comment on this publication
|
|
Project ref: |
04/24/01 |
Original project title: |
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration |
Chief Investigator: |
Southampton Health Technology Assessment Centre (SHTAC), University of Southampton |
Start Date: |
May 2006. |
Publication date: |
May 2008 |
Cost: |
This project was commissioned by the HTA programme on behalf of the National Institute for Health and Clinical Excellence on a call-off contract basis |
MeSH* index primary terms: |
MACULAR-DEGENERATION Q-drug-therapy; RANIBIZUMAB Q-administration-&-dosage; PEGAPTANIB Q-administration-&-dosage (* = Medical Subject Headings) |
MeSH* index secondary terms: |
HUMANS (* = Medical Subject Headings) |
NRR* number, if applicable: |
N0484184710 (*National Research Register) |
Project Protocol: |
Project protocol not available |
Printed copies of this title despatched: |
100 (Figures relate to the previous calendar month) |
Downloads/Views of electronic version from website: |
3390 (Figures are cumulative.) Last updated 8th July 2008. |
URL of this page: |
http://www.hta.ac.uk/1528 |
News feeds